At DIVINCELL, we are developing the natural delivery and targeting capabilities of peptides, to offer an entirely novel class of therapeutic agents for the treatment of cancer and genetic diseases.
DIVINCELL is a BioPharmaceutical NanoMedicine company, pioneering novel peptide-based nanotechnology for targeted drug delivery.
The Nanocage DIV’INTM technology is versatile nanoparticulate system, enabling the protection, packaging and tissue or cell targeting of biomacromolecules.
DIVINCELL is working to create novel nanocage-based therapeutics for a wide range of severe pathologies with limited treatment options.
